Home > Press > BIO Issues Call for Session Proposals for 2008 BIO International Convention
The Biotechnology Industry Organization (BIO) invites leaders in science, finance, business, law, and government policy to submit proposals for breakout sessions at the 2008 BIO International Convention to be held June 17-20 at the San Diego Convention Center. The day pattern will change from previous years to Tuesday-Friday.
BIO Issues Call for Session Proposals for 2008 BIO International Convention
Washington, DC | Posted on June 11th, 2007
The BIO International Convention continues to be the number one resource for the latest information and the newest opportunities for executives, investors, scientists, policy leaders, and journalists from around the world. Speakers at the sessions will share breakthroughs in medicine, diagnostics, the environment, energy production, food and agriculture, and more with a global audience of an estimated 24,000 attendees.
The convention will feature more than 200 breakout sessions in 21 educational session tracks, including biodefense; bioethics; clinical research/clinical trials; devices and diagnostics; drug discovery and development; emerging company issues; finance; food and agriculture; industrial and environmental; intellectual property/legal; manufacturing; nanotechnology; technology transfer/licensing and other key business areas for doing biotech business globally.
The most popular educational tracks from the 2007 BIO International Convention included business development, clinical research, devices and predictive diagnostics and technology transfer. Super Sessions, Biotech Entrepreneurship Boot Camp and the Translational Research Forum all drew significant attendance.
Applications for educational sessions will only be accepted online, at http://www.bio2008.org/Attendees/program.html. The online application process closes on Friday, September 7th at 5:00 pm EDT.
All proposals will be reviewed by BIO staff, the standing BIO Program Committee and a local Program Committee composed of biotechnology professionals. Applicants will be notified of the status of their session proposal beginning early November 2007.
The 2007 BIO International Convention drew a record 22,366 attendees, a nearly 15 percent increase from the previous year, with representatives from 48 states and one-third of attendees from outside the United States.
About Biotechnology Industry Organization (BIO)
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the global event for biotechnology.
Upcoming BIO Events
-- BIO VentureForum-East 2007
June 18-20, 2007
-- BIO Mid-America VentureForum 2007
Sept. 24-26, 2007
-- BIO InvestorForum 2007
Oct. 9-11, 2007
San Francisco, Calif.
-- BIO-Europe 2007 International Partnering Conference
Nov. 12-14, 2007
-- Pacific Rim Summit on Industrial Biotechnology and Bioenergy
Nov. 14-17, 2007
For more information, please click here
Biotechnology Industry Organization (BIO)
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Aerotech X-Y ball-screw stage for economical high performance Planar positioning April 16th, 2014
Energy Research Facility Construction Project at Brookhaven Lab Wins U.S. Energy Secretary's Achievement Award April 16th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Nanoparticles cause cancer cells to self-destruct April 3rd, 2014
A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014
Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014
'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014
ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014
Engineers develop new materials for hydrogen storage April 15th, 2014
Near-field Nanophotonics Workshop in Boston April 14th, 2014